Skip to main content
PMC home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2010 May 27;25(2):208–212. doi: 10.1007/s12291-010-0037-7

hs-CRP: A potential marker for hypertension in Kashmiri population

M Shafi Dar 1, A A Pandith 2, A S Sameer 1,2, M Sultan 3, A Yousuf 1, Syed Mudassar 1,✉
PMCID: PMC3453101  PMID: 23105911

Abstract

Hypertension is the most important public health problem in developing countries and one of the major risk factors for cardiovascular diseases, and it has been reported that hypertension is in part an inflammatory disorder and several workers have reported elevated levels of CRP in hypertensive individuals. The main aim of the present study was to evaluate the association between blood pressure and serum CRP levels across the range of blood pressure categories including prehypertension. A total of 104 patients and 63 control subjects were included in the present study. The level of CRP in the serum samples was estimated by a high sensitivity immunoturbidometric assay. Standard unpaired student’s ‘t’ test was used for comparison of hs-CRP levels between hypertensive patients and normotensive control subjects and between patient groups with different grades of hypertension and different durations of hypertensive histories. The mean serum hs-CRP level in hypertensive patients was 3.26 mg/L compared with 1.36 mg/L among normotensive control subjects (P<0.001). On comparison with normotensive control subjects, the hs-CRP levels vary significantly both with grades and duration of hypertension, with most significant difference found in patients with prehypertension (P<0.001), followed by Stage-I (P=0.01) and Stage-II(P=0.02) hypertensives. Significant difference in hs-CRP levels was also found in patients with shorter duration of hypertensive history (≤ 1year) when compared with those with ≥5 years of hypertensive history (P<0.01). Our study reveals a graded association between blood pressure and CRP elevation in people with hypertension. Individuals with prehypertension or with shorter duration of hypertension (≤1 Year) had significantly a greater likelihood of CRP elevation in comparison to chronic stage-I or stage-II hypertensives.

Key Words: Hypertension, Inflammatory disorder, hs-CRP, Stage I

Full Text

The Full Text of this article is available as a PDF (69.2 KB).

References

  • 1.Naomi DLF, Gordon HW. Hypertensive Vascular Disease. Harrison’s Principles of Internal Medicine. 16th Edition. Part Eight; Section Four; Chapter 246; 1463–1470.
  • 2.Whelton P.K. Epidemiology and the Prevention of Hypertension. J Clin Hypertens. 2004;6:636–642. doi: 10.1111/j.1524-6175.2004.03609.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.King D.E., Egan B.M., Mainous A.G., 3rd, Geesey M.E., et al. Elevation of C — Reactive protein in People with Prehypertension. J Clin Hypertens. 2004;6:562–568. doi: 10.1111/j.1524-6175.2004.03577.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Albert M.A., Glynn R.J., Buring J., Ridker P.M. C-Reactive Protein Levels Among Women Of Various Ethnic Groups Living in the United States (from the Women’s Health Study) Am J Cardiol. 2004;93:1238–1242. doi: 10.1016/j.amjcard.2004.01.067. [DOI] [PubMed] [Google Scholar]
  • 5.Li J.-jun. Inflammation in hypertension: primary evidence. Chin Med J. 2006;119:1215–1221. [PubMed] [Google Scholar]
  • 6.Pauleto P., Rattazzi M. Inflammation and Hypertension: the search for a link. Nephrol Dial Transplant. 2006;21:850–853. doi: 10.1093/ndt/gfl019. [DOI] [PubMed] [Google Scholar]
  • 7.Liby P., Ridker M., Maseri A. Inflammation and Atherosclerosis. Circulation. 2002;105:1135–1143. doi: 10.1161/hc0902.104353. [DOI] [PubMed] [Google Scholar]
  • 8.Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Eng J Med. 2000;342:836–843. doi: 10.1056/NEJM200003233421202. [DOI] [PubMed] [Google Scholar]
  • 9.Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., Gallimore J.R., Pepys M.B. Low grade inflammation and coronary heart disease: prospective study and updated meta-analysis. BMJ. 2000;321:199–204. doi: 10.1136/bmj.321.7255.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Koenig W., Sund M., Frohlich M., Fischer H.G., Lowel H., Doring A., Hutchinson W.L., Pepys M.B. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy, middle-aged men; results from MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study 1984–1992. Circulation. 1999;99:237–242. doi: 10.1161/01.cir.99.2.237. [DOI] [PubMed] [Google Scholar]
  • 11.Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of Creactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347:1557–1565. doi: 10.1056/NEJMoa021993. [DOI] [PubMed] [Google Scholar]
  • 12.Person T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., III, Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for health-care professionals from the Centers for Disease Control and Prevention (CDC) and the American Heart association (AHA) Circulation. 2003;107:499–511. doi: 10.1161/01.CIR.0000052939.59093.45. [DOI] [PubMed] [Google Scholar]
  • 13.Ridker P.M., Stampfer M.J., Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001;285:2481–2485. doi: 10.1001/jama.285.19.2481. [DOI] [PubMed] [Google Scholar]
  • 14.Hirschfield G.M., Pepys M.B. C-reactive protein and Cardiovascular Disease: new insights from an old molecule. Q J Med. 2003;96:793–807. doi: 10.1093/qjmed/hcg134. [DOI] [PubMed] [Google Scholar]
  • 15.Napoli M., Schwaninger M., Cappelli R., Ceccarelli E., Gianfilippo G., Donati C., et al. Evaluation of C-reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke; A Statement for Health Care Professionals from the CRP Pooling Project Members. Stroke. 2005;36:1316–1329. doi: 10.1161/01.STR.0000165929.78756.ed. [DOI] [PubMed] [Google Scholar]
  • 16.Black S., Kushner I., Samols D. C-reactive protein. J Biol Chem. 2004;279:48487–48490. doi: 10.1074/jbc.R400025200. [DOI] [PubMed] [Google Scholar]
  • 17.Boos C.J., Lip G.Y.H. Elevated high-sensitivity C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension? J Human Hypertens. 2005;19:511–513. doi: 10.1038/sj.jhh.1001858. [DOI] [PubMed] [Google Scholar]
  • 18.Sesso H.D., Buring J.E., Rifai N., Blake G.J., Gaziano J.M., Ridker P.M. C-Reactive Protein and the Risk of Developing Hypertension. JAMA. 2003;290:2945–2951. doi: 10.1001/jama.290.22.2945. [DOI] [PubMed] [Google Scholar]
  • 19.Sung K.C., Suh J.Y., Kim B.S., Kang J.H., Kim H., Lee M.H., Park J.R., Kim S.W. High-sensitivity C-reactive protein as an independent risk factor for essential hypertension. Am J Hypertension. 2003;16(6):429–433. doi: 10.1016/S0895-7061(03)00566-1. [DOI] [PubMed] [Google Scholar]
  • 20.Davey Smith G., Lawlor D.A., Harbord R., Timpson N., Rumley A., Lowe G.D., Day I.N., Ebrahim S. Association of C-Reactive Protein With Blood Pressure and Hypertension. ArteriosclerosisThromb Vascular Biol. 2005;25:1051–1060. doi: 10.1161/01.ATV.0000160351.95181.d0. [DOI] [PubMed] [Google Scholar]
  • 21.Fernandez-Real J.M., Vayreda M., Richart C., Gutierrez C., Broch M., Vendrell J., Ricart W. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab. 2001;86:1154–1159. doi: 10.1210/jc.86.3.1154. [DOI] [PubMed] [Google Scholar]
  • 22.Lakoski S.G., Cushman M., Palmas W., Blumenthal R., D’Agostino R.B., Jr, Herrington D.M. The Relationship between Blood Pressure and C-reactive protein in the Multi-Ethnic Study of Atherosclerosis (MESA) J Am Coll Cardiol. 2005;46:1869–1874. doi: 10.1016/j.jacc.2005.07.050. [DOI] [PubMed] [Google Scholar]
  • 23.Wung B.S., Cheng J.J., Chao Y.J., Lin J., Shyy Y.J., Wang D.L. Cyclical strain increases monocyte chemotactic protein-1 secretion in human endothelial cells. Am J Physiol. 1996;270:1462–1468. doi: 10.1152/ajpheart.1996.270.4.H1462. [DOI] [PubMed] [Google Scholar]
  • 24.Wang D.L., Wung B.S., Shyy Y.J., Lin C.F., Chao Y.J., Usami S., Chien S. Mechanical strain induces monocyte chemotactic protein-1 gene expression in endothelial cells: effects of mechanical strain on monocyte adhesion to endothelial cells. Circ Res. 1995;77:294–302. doi: 10.1161/01.res.77.2.294. [DOI] [PubMed] [Google Scholar]
  • 25.Capers Q, Alexander RW, Lou P, De Leon H, Wilcox JN, Ishizaka N, Howard AB, Taylor WR. Monocyte chemoattractant protein-1 expression in aortic tissue of hypertensive rats. Hypertens 197; 30: 1397–1402. [DOI] [PubMed]
  • 26.Chobanian A.V., Alexander R.W. Exacerbation of atherosclerosis by hypertension: potential mechanisms and clinical implications. Arch Intern Med. 1996;156:1952–1956. doi: 10.1001/archinte.156.17.1952. [DOI] [PubMed] [Google Scholar]
  • 27.Yasunari K., Maeda K., Nakamura M., Yoshikawa J. Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose and C-reactive protein. Hypertens. 2002;39:777–780. doi: 10.1161/hy0302.104670. [DOI] [PubMed] [Google Scholar]
  • 28.Sinisalo J., Paronen J., Mattila K.J., Syrjala M., Alfthan G., Palosuo T., Nieminen M.S., Vaarala O. Relation of inflammation to vascular function in patients with coronary heart disease. Atherosclerosis. 2000;149:403–411. doi: 10.1016/S0021-9150(99)00333-0. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES